Spinal Cord Stimulation Devices

Spinal Cord Stimulation Devices Market Outlook

The global spinal cord stimulation devices market is anticipated to reach USD 5.1 billion by 2035, growing at a CAGR of 10.5% from 2025 to 2035. The increasing prevalence of chronic pain conditions and the rise in the geriatric population requiring pain management are significant factors driving market growth. Moreover, advancements in technology and a growing preference for non-invasive therapeutic options over traditional surgical interventions are stimulating demand for spinal cord stimulators. As healthcare systems worldwide emphasize reducing opioid dependency through alternative pain management solutions, the spinal cord stimulation devices market is poised for substantial growth. Increasing investments in healthcare infrastructure and rising awareness regarding pain management therapies further bolster the market's potential.

Growth Factor of the Market

One of the primary growth factors for the spinal cord stimulation devices market is the dramatic rise in the incidence of chronic pain conditions, including neuropathic pain, which afflicts millions globally. Additionally, the aging population, particularly in developed nations, is contributing to a higher prevalence of conditions such as degenerative disc disease, which often necessitates spinal interventions. Technological advancements in spinal cord stimulation devices have also played a critical role by introducing more effective and patient-friendly options, leading to improved patient outcomes and satisfaction. Furthermore, the growing trend towards minimally invasive surgical techniques in pain management has made spinal cord stimulators a preferred choice for both healthcare providers and patients. The shift in regulatory policies towards enhancing patient access to effective pain management solutions is another factor driving market growth, ensuring the availability of innovative devices in various regions.

Key Highlights of the Market

• Robust growth driven by increasing chronic pain cases and advancements in technology.
• Expanding applications in various pain syndromes and conditions.
• Significant investments in research and development activities by major players.
• Emerging markets are showing rising demand for spinal cord stimulators.
• Shift towards outpatient and minimally invasive procedures enhancing market penetration.

By Product Type

Implantable Pulse Generator:

Implantable pulse generators are integral components of spinal cord stimulation systems, as they deliver electrical pulses to the spinal cord to modulate pain signals. These devices are typically surgically implanted, and their adoption is driven by their effectiveness in treating various chronic pain syndromes. The rising prevalence of conditions like failed back surgery syndrome (FBSS) is bolstering the demand for implantable pulse generators. Additionally, technological advancements have led to the development of rechargeable devices, reducing the frequency of replacement surgeries and enhancing patient convenience. The increasing focus on improving patient outcomes and the ongoing innovations in pulse generator designs are expected to further fuel the growth of this segment.

Radiofrequency System:

Radiofrequency systems are gaining traction in the spinal cord stimulation devices market due to their non-invasive nature and effectiveness in pain management. These systems utilize radiofrequency energy to disrupt nerve conduction pathways, offering an alternative for patients who may not respond well to traditional spinal cord stimulators. The growing acceptance of radiofrequency ablation techniques in clinical settings is a significant factor contributing to the rise in utilization of these systems. Moreover, the ability to perform radiofrequency procedures in an outpatient setting is appealing to both patients and healthcare providers, driving the demand for radiofrequency systems in managing chronic pain conditions.

External Trial Stimulator:

External trial stimulators play a crucial role in the spinal cord stimulation process by allowing healthcare providers to assess the efficacy of spinal cord stimulation before permanent implantation. This trial phase is essential for determining a patient's suitability for long-term therapy, and as such, the demand for external trial stimulators is expected to grow. The increasing emphasis on patient-centered care and the need for personalized treatment approaches are further propelling the use of these devices. Additionally, advancements in external trial stimulator technologies are enhancing their ease of use and effectiveness, thereby supporting market growth.

Others:

The 'Others' segment within product types encompasses various emerging devices and technologies that are being integrated into spinal cord stimulation systems. This includes innovative delivery systems and non-invasive stimulation devices that promise to broaden the therapeutic scope of spinal cord stimulation. The continuous evolution of technology, including wearable devices, is expected to provide alternatives for patients who may require less invasive forms of pain management. As research progresses, these new products could play a significant role in future market dynamics by offering patients additional options for effective pain relief without the need for invasive surgeries.

By Application

Failed Back Surgery Syndrome:

Failed Back Surgery Syndrome (FBSS) is a prevalent condition that often leads to chronic pain post-surgery, which can create a substantial demand for spinal cord stimulation devices. Many patients with FBSS experience inadequate pain relief from traditional analgesics, making spinal cord stimulation a viable treatment alternative. The growing recognition of spinal cord stimulation's benefits in managing FBSS is contributing to market expansion. Additionally, healthcare professionals are increasingly relying on spinal cord stimulators to improve quality of life for patients who have undergone unsuccessful surgeries, thereby driving further growth in this application segment.

Complex Regional Pain Syndrome:

Complex Regional Pain Syndrome (CRPS) is a debilitating condition characterized by severe chronic pain, often following an injury or surgery. The rising incidence of CRPS and the challenges in managing its symptoms through conventional methods have led to an increased demand for spinal cord stimulation as a therapeutic option. The effectiveness of spinal cord stimulation in alleviating CRPS symptoms has gained attention in recent years, prompting more healthcare providers to recommend this treatment. As a result, advancements in spinal cord stimulation technology tailored for CRPS are likely to enhance their clinical adoption and significantly grow this segment of the market.

Ischemic Pain:

Ischemic pain, resulting from inadequate blood flow to tissues, is another critical area where spinal cord stimulation devices are being utilized. Patients suffering from ischemic pain often experience debilitating symptoms that adversely affect their quality of life. The application of spinal cord stimulation as a method to alleviate ischemic pain is gaining momentum due to its ability to interrupt pain pathways effectively. As awareness of this therapy's potential increases among clinicians and patients alike, it is expected that the market for spinal cord stimulators focused on ischemic pain will see significant growth in the coming years.

Others:

The 'Others' application segment includes various chronic pain conditions that may not fall into the major categories like FBSS, CRPS, or ischemic pain. This segment encompasses a range of conditions such as neuropathic pain and postoperative pain, where spinal cord stimulation can provide significant relief. The growing body of clinical evidence supporting the use of spinal cord stimulators for diverse pain conditions is likely to boost the adoption of these devices across multiple indications. As healthcare practitioners seek more solutions for complex pain management, this segment is expected to continue expanding in the overall spinal cord stimulation devices market.

By End User

Hospitals:

Hospitals represent a key end-user segment in the spinal cord stimulation devices market, as they provide advanced healthcare services and are equipped with specialized staff to manage complex pain conditions. The availability of comprehensive facilities, along with access to the latest technologies, makes hospitals the primary setting for spinal cord stimulation procedures. The increasing hospital admissions for chronic pain management, coupled with healthcare policies promoting effective pain relief strategies, is driving the demand for spinal cord stimulators within this segment. Furthermore, the ongoing investments in hospital infrastructure and advanced surgical technologies are expected to enhance this market's growth.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly popular for performing spinal cord stimulation procedures due to their focus on outpatient care, reduced wait times, and cost-effectiveness. These centers allow patients to undergo minimally invasive procedures and return home the same day, making them a favorable option for both patients and providers. The rise in patient preference for outpatient surgical options is significantly contributing to the growth of spinal cord stimulators being utilized in ASCs. Additionally, ASCs are adopting advanced technologies, including spinal cord stimulation, to enhance patient care and expand their service offerings in pain management.

Specialty Clinics:

Specialty clinics focused on pain management have emerged as vital end-users of spinal cord stimulation devices. These clinics concentrate on treating patients with chronic pain, thereby creating a steady demand for spinal cord stimulators and related procedures. The personalized approach offered by specialty clinics allows for tailored treatment plans, which often include spinal cord stimulation as an effective option. With an increasing number of patients seeking specialized treatment for chronic pain conditions, these clinics are likely to see significant growth in the use of spinal cord stimulators in the coming years. The continued development of multidisciplinary teams within these clinics further enhances the appeal of spinal cord stimulation devices in managing complex pain syndromes.

Others:

The 'Others' segment under end users encompasses various healthcare facilities and organizations that utilize spinal cord stimulation devices, including rehabilitation centers and research institutions. These entities focus on long-term patient care and rehabilitation, where spinal cord stimulation can play a critical role in enhancing recovery outcomes. The adoption of spinal cord stimulators in these settings underscores their versatility in treating different pain conditions. As more healthcare facilities recognize the importance of effective pain management strategies, the demand for spinal cord stimulation devices in this segment is expected to rise, contributing to the overall growth of the market.

By Technology

Conventional Spinal Cord Stimulation:

Conventional spinal cord stimulation (SCS) is a well-established technology that has been used for decades to manage chronic pain conditions. This technology involves the implantation of a pulse generator that delivers electrical impulses to the spinal cord, effectively disrupting pain signals. Its long history of clinical success and wide acceptance among healthcare providers make it a dominant segment within the spinal cord stimulation devices market. Recent advancements in conventional SCS technology, including improved battery life and smaller device sizes, have further enhanced its attractiveness to patients and clinicians. As the foundation of spinal cord stimulation therapy, conventional SCS continues to evolve, with ongoing research aimed at optimizing its efficacy and expanding its applications.

High-Frequency Spinal Cord Stimulation:

High-frequency spinal cord stimulation (HF-SCS) is an emerging technology that delivers electrical pulses at higher frequencies, typically above 1 kHz, which has been shown to provide effective pain relief without the tingling sensation associated with traditional SCS. This advancement is particularly appealing to patients who are sensitive to sensations or prefer a more comfortable treatment option. The growing body of clinical evidence supporting the efficacy of HF-SCS in managing various chronic pain conditions is driving its adoption. As technology continues to advance, HF-SCS is expected to gain a larger market share within the spinal cord stimulation devices segment, providing patients with innovative and effective solutions for pain relief.

Burst Spinal Cord Stimulation:

Burst spinal cord stimulation (Burst SCS) is a novel approach that delivers electrical impulses in bursts, mimicking the body's natural pain modulation processes. This technology has shown promise in improving pain relief and overall patient satisfaction compared to traditional SCS methods. Burst SCS is particularly beneficial for patients who may not respond adequately to conventional stimulation techniques. The increasing recognition of the effectiveness of Burst SCS in providing targeted pain relief is contributing to its growing popularity among healthcare providers and patients alike. As clinical research continues to support its advantages, Burst SCS is poised to become a significant player in the spinal cord stimulation devices market.

Others:

The 'Others' segment within technology refers to various innovative approaches and devices that are currently in development or being evaluated for spinal cord stimulation therapies. These may include technologies such as closed-loop systems and non-invasive stimulation methods that seek to enhance the efficacy of pain management therapies. The continuous evolution of spinal cord stimulation technology is likely to provide new avenues for treating chronic pain conditions, further expanding the market. As research and development efforts continue, these emerging technologies are expected to play a vital role in shaping the future of spinal cord stimulation, catering to the diverse needs of patients and healthcare providers.

By Region

The regional analysis of the spinal cord stimulation devices market reveals varying levels of growth and development across different parts of the world. North America holds a leading position, accounting for over 40% of the global market share in 2023, primarily due to the high prevalence of chronic pain disorders, advanced healthcare infrastructure, and significant investments in medical technology. The United States, in particular, shows a strong demand for spinal cord stimulators owing to the country’s high healthcare expenditure and the increasing acceptance of new treatment modalities among healthcare professionals. Furthermore, the compound annual growth rate (CAGR) for the North American market is projected to be around 11% through 2035, driven by innovations in spinal cord stimulation technologies and an expanding patient population in need of effective pain management solutions.

Europe also presents a robust market for spinal cord stimulation devices, with a market share of approximately 25% as of 2023. The increasing awareness of advanced pain management techniques and supportive healthcare policies are facilitating market growth in this region. Countries such as Germany, France, and the United Kingdom are leading in adopting spinal cord stimulation technologies, primarily due to their established healthcare systems and research initiatives focused on chronic pain treatment. The European market is expected to grow at a CAGR of around 9% during the forecast period, driven by ongoing innovations in spinal cord stimulation devices and the rising demand for non-invasive pain management therapies. Emerging markets in the Asia Pacific region, particularly China and India, are also expected to witness substantial growth due to rising healthcare expenditure and improving access to advanced medical technologies.

Opportunities

The spinal cord stimulation devices market is characterized by a multitude of opportunities for growth and innovation. One of the most significant opportunities lies in the expansion of clinical applications for spinal cord stimulators, particularly in treating conditions that may not have traditionally been associated with this therapy. As research continues to elucidate the potential benefits of spinal cord stimulation in managing a wider array of pain syndromes, manufacturers can capitalize on this by developing targeted products and specific treatment protocols. Moreover, the increasing demand for personalized medicine is encouraging healthcare providers to explore tailored pain management solutions, further driving the potential for spinal cord stimulators as versatile treatment options. The combination of ongoing clinical research and technological advancements presents a fertile ground for the development of new and improved devices, enhancing the market's overall growth potential.

Another opportunity arises from the rising global emphasis on the reduction of opioid dependency in pain management. As healthcare systems strive to provide effective alternatives to opioids, spinal cord stimulators offer a viable and less addictive option for chronic pain patients. The growing awareness among clinicians and patients regarding the risks associated with long-term opioid use is prompting a shift toward more sustainable pain management strategies. Additionally, expanding healthcare access in emerging markets presents a unique opportunity for the spinal cord stimulation devices market. As these regions invest in advanced medical technologies and improve healthcare infrastructure, the demand for effective pain management solutions is expected to surge, enabling manufacturers to tap into new markets and realize substantial growth.

Threats

While the spinal cord stimulation devices market presents numerous opportunities, it is not without its challenges. One notable threat is the increasing competition among manufacturers, particularly with the entry of new players into the market. As more companies invest in the development of innovative spinal cord stimulation devices, the market may become saturated, leading to price pressures and reduced profit margins for established companies. Additionally, the rapid pace of technological advancements necessitates that manufacturers continuously innovate to stay competitive, which can strain resources and increase costs. Furthermore, the regulatory landscape surrounding medical devices is becoming more stringent, and failure to comply with evolving regulations could hinder the market growth of certain products.

Another significant threat to the spinal cord stimulation devices market is the potential for adverse events associated with the use of these devices. While spinal cord stimulators have been shown to be safe and effective, complications can occur, such as infection or lead migration, which may deter healthcare providers from recommending these therapies. Additionally, negative clinical outcomes or poor patient experiences can lead to skepticism regarding spinal cord stimulation, impacting the overall market growth. Ensuring robust clinical evidence and patient education regarding the use of spinal cord stimulators is essential to mitigate these threats and foster continued acceptance of this treatment modality.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• Baxter International Inc.
• NeuroMetrix, Inc.
• Stimwave Technologies Incorporated
• Horizon Therapeutics plc
• Implantable Technologies, Inc.
• Saluda Medical Pty Ltd
• Nuvectra Corporation
• Axonics Modulation Technologies, Inc.
• Zynex Inc.
• Evolution Medtech
• Medisystems Corporation

The competitive landscape of the spinal cord stimulation devices market is characterized by a mix of established players and emerging companies, all vying for market share in a rapidly evolving industry. Major companies such as Medtronic, Boston Scientific, and Abbott Laboratories dominate the market, leveraging their extensive research and development capabilities to innovate and introduce new products that meet the growing demand for effective pain management therapies. These companies have established strong distribution networks and robust marketing strategies, enabling them to maintain a significant presence in the market. Furthermore, ongoing collaborations and strategic partnerships within the industry are fostering advancements in spinal cord stimulation technologies, contributing to overall market growth and competitiveness.

In addition to the key players, numerous emerging companies are entering the spinal cord stimulation market, seeking to differentiate themselves through innovative product offerings and targeted therapies. Companies like Stimwave Technologies and Nuvectra are focusing on developing next-generation devices that prioritize patient comfort and usability, providing new alternatives to traditional spinal cord stimulators. As competition intensifies, these companies bring fresh perspectives and innovative solutions to the market, potentially reshaping the landscape of spinal cord stimulation therapies. The rise of digital health technologies is also influencing the competitive environment, as companies explore ways to integrate telemedicine and remote monitoring into their spinal cord stimulation systems, enhancing patient engagement and outcomes.

Overall, the competitive landscape of the spinal cord stimulation devices market is dynamic and continually evolving, with established players, emerging companies, and evolving technologies presenting diverse opportunities and challenges. As the demand for effective pain management solutions continues to grow, companies in this market must remain agile, adapt to changing market dynamics, and prioritize innovation to maintain their competitive edge. The focus on improving patient outcomes and quality of life will be paramount for all stakeholders as they navigate the complexities of this market and strive to advance the field of spinal cord stimulation.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Zynex Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Evolution Medtech
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 NeuroMetrix, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Stryker Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Nuvectra Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Saluda Medical Pty Ltd
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Medisystems Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Horizon Therapeutics plc
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Baxter International Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Boston Scientific Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Implantable Technologies, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Stimwave Technologies Incorporated
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Axonics Modulation Technologies, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Spinal Cord Stimulation Devices Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Spinal Cord Stimulation Devices Market, By Technology
    • 6.2.1 Conventional Spinal Cord Stimulation
    • 6.2.2 High-Frequency Spinal Cord Stimulation
    • 6.2.3 Burst Spinal Cord Stimulation
    • 6.2.4 Others
  • 6.3 Spinal Cord Stimulation Devices Market, By Application
    • 6.3.1 Failed Back Surgery Syndrome
    • 6.3.2 Complex Regional Pain Syndrome
    • 6.3.3 Ischemic Pain
    • 6.3.4 Others
  • 6.4 Spinal Cord Stimulation Devices Market, By Product Type
    • 6.4.1 Implantable Pulse Generator
    • 6.4.2 Radiofrequency System
    • 6.4.3 External Trial Stimulator
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Spinal Cord Stimulation Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Spinal Cord Stimulation Devices market is categorized based on

By Product Type

• Implantable Pulse Generator
• Radiofrequency System
• External Trial Stimulator
• Others

By Application

• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Ischemic Pain
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Technology

• Conventional Spinal Cord Stimulation
• High-Frequency Spinal Cord Stimulation
• Burst Spinal Cord Stimulation
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• Baxter International Inc.
• NeuroMetrix, Inc.
• Stimwave Technologies Incorporated
• Horizon Therapeutics plc
• Implantable Technologies, Inc.
• Saluda Medical Pty Ltd
• Nuvectra Corporation
• Axonics Modulation Technologies, Inc.
• Zynex Inc.
• Evolution Medtech
• Medisystems Corporation